Journal of Clinical & Experimental Pathology
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 1437
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Jinsong Liu
Jinsong Liu
Professor
Department of Pathology
University of Texas
USA
Tel: 713-745-1102
Fax: 713-563-1848
Biography
Jinsong Liu. MD, PhD is a professor with tenure in the Department of Pathology at The University of Texas M. D. Anderson Cancer Center. He graduated from Shanghai First Medical College (now Fudan University), China, and came to US through China-United States Biochemistry Examination Program (CUSBEA) 1984, received a master degree from Indiana University and a Ph.D. in Biochemistry from Case Western Reserve University in 1991. He completed postdoctoral training at Howard Hughes Medical Institute and the University of Michigan. After finishing a pathology residency and surgical pathology fellowship at New York University, He joined M. D. Anderson Cancer Center in 1999 as an Assistant Professor and was promoted to Associate Professor (2004) and professor with tenure (2009).
Research Interest
Dr. Liu is an active diagnostic pathologist specialized in gynecologic malignancy and also directs extramurally funded research program focusing on ovarian cancer development. His research has been funded more than 20 grants including R01 and from and Specialized Programs of Research Excellence (SPORE) in ovarian cancer from NCI/NIH, and Cancer Prevention and Research Institute of Texas (CRPIT), and Ovarian Cancer Research Fund.
Certificate
